Clinical Trial Update: Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quetiapine augmentation for primary anxiety disorders and mood disorders with comorbid anxiety symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Mood Disorders

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Primary Anxiety Disorders, Mood Disorders With Comorbid Anxiety Symptoms | Phase 4 | Status: COMPLETED